AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DICLOFENAC POTASSIUM 50 Mg ;

9 registrations across 1 African market— 9 active

Markets with DICLOFENAC POTASSIUM 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Diclofenac Potassium - High Performance Pharma
Film Coated Tablets
🇪🇬EgyptHigh Performance Pharma - HP Pharmaactive
Vantomor
Powder for oral solution
🇪🇬EgyptHygint Pharmaceuticalsactive
Vantomor
Powder for oral solution
🇪🇬EgyptHygint Pharmaceuticalsactive
Diclopro K
Granules for Oral Solution
🇪🇬EgyptXeedia Pharmaceuticalsactive
Diclopro K
Granules for Oral Solution
🇪🇬EgyptXeedia Pharmaceuticalsactive
Declophen Fast
Granules for Oral Solution
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Catafast ® 50 mg
Granules for Oral Solution
🇪🇬EgyptNovartis Pharmaactive
Catafast ® 50 mg
Granules for Oral Solution
🇪🇬EgyptNovartis Pharmaactive
Declophen Fast
Granules for Oral Solution
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive

DICLOFENAC POTASSIUM 50 Mg ; in Africa — Regulatory Overview

DICLOFENAC POTASSIUM 50 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.